Cusabio Polyclonal Antibodies
GABARAPL2 Antibody, FITC conjugated | CSB-PA03485C0Rb
- SKU:
- CSB-PA03485C0Rb
- Availability:
- 3 to 7 Working Days
Description
GABARAPL2 Antibody, FITC conjugated | CSB-PA03485C0Rb | Cusabio
GABARAPL2 Antibody, FITC conjugated is Available at Gentaur Genprice with the fastest delivery.
Online Order Payment is possible or send quotation to info@gentaur.com.
Product Type: Polyclonal Antibody
Target Names: GABARAPL2
Aliases: Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA (A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein), GABARAPL2, FLC3A GEF2
Background: Ubiquitin-like modifier involved in intra-Golgi traffic. Modulates intra-Golgi transport through coupling between NSF activity and SNAREs activation. It first stimulates the ATPase activity of NSF which in turn stimulates the association with GOSR1 (By similarity) . Involved in autophagy. Plays a role in mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation.
Isotype: IgG
Conjugate: FITC
Clonality: Polyclonal
Uniport ID: P60520
Host Species: Rabbit
Species Reactivity: Human
Immunogen: Recombinant Human Gamma-aminobutyric acid receptor-associated protein-like 2 protein (1-117AA)
Immunogen Species: Human
Applications: ELISA
Tested Applications: ELISA
Purification Method: >95%, Protein G purified
Dilution Ratio1:
Dilution Ratio2:
Dilution Ratio3:
Dilution Ratio4:
Dilution Ratio5:
Dilution Ratio6:
Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form: Liquid
Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Initial Research Areas: Others
Research Areas: Others